CancerAid Revenue and Competitors

CancerAid empowers the cancer community through digital empathy-driven innovation on a global scale. CancerAid has quickly become the go-to resource for people affected by cancer and is the Number 1 cancer app currently on the Apple Store in Australia, the US and the UK. The app addresses issues faced in oncology through science-based technology solutions. Over 20,000 users across 53 countries are already engaged with the CancerAid platform. CancerAid has been fortunate to achieve growing recognition of its work. CancerAid has won a number of awards including Best Global Startup 2017 (Talent Unleashed), judged by Steve Wozniak and Sir Richard Branson, AusBiotech Emerging Company of the Year 2017, and has been featured by leading media outlets including TechCrunch, Shark Tank (Australia) and HealthXL. CancerAid was named Apple's flagship health app in a press announcement shortly after launch: http://bit.ly/apple_canceraid As a health-tech startup, not only has the company raised significant seed investment, but taken the product to market, and secured large customers. See how CancerAid became a Shark Tank winner: https://www.youtube.com/watch?v=NqGIdyLE_Nw&t=75s Cancer patients expect, need and deserve timely access to the best possible care. CancerAid aims to achieve this. The cancer roadmap is shifting, and CancerAid is the roadmap to change. CancerAid is a signatory to the Health Benefits of Good Work Charter by the Royal Australian College of Physicians (RACP) and the Australasian Faculty of Occupational and Environmental Medicine (AFOEM). The charter aims to promote the benefits of good work on people's health and wellbeing. The app is available to download and use for free: http://bit.ly/CancerAid